Search

Jazz Pharmaceuticals PLC

Закрыт

СекторЗдравоохранение

244.94 0.04

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

243.33

Макс.

245.05

Ключевые показатели

By Trading Economics

Доход

-100M

193M

Продажи

139M

1.2B

P/E

Средняя по отрасли

17.558

57.002

Прибыль на акцию

4.89

Рентабельность продаж

15.956

Сотрудники

2,890

EBITDA

-126M

418M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+16.83% upside

Дивиденды

By Acuity

Следующий отчет о доходах

4 нояб. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

768M

17B

Предыдущая цена открытия

244.9

Предыдущая цена закрытия

244.94

Новостные настроения

By Acuity

67%

33%

287 / 340 Рейтинг в Healthcare

Jazz Pharmaceuticals PLC График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

12 авг. 2026 г., 19:46 UTC

News

Jazz Pharmaceuticals shares are higher after Q2 revenue rose 16% to $1.21 billion, exceeding expectations. The company raised its full-year guidance to $4.68 billion.

11 авг. 2026 г., 22:46 UTC

Jazz Pharmaceuticals PLC shares advanced in after-market trading, diverging from broader market trends that closed lower amid rising crude oil prices.

10 авг. 2026 г., 19:56 UTC

Event
Social Media
News

Jazz Pharmaceuticals PLC to acquire Actio Biosciences for $820 million, enhancing its rare epilepsy portfolio. Shares are higher despite earlier session pullback.

7 авг. 2026 г., 19:36 UTC

Jazz Pharmaceuticals shares are higher today, reflecting broader market gains amid expectations the Federal Reserve may pause interest rate hikes.

6 авг. 2026 г., 19:21 UTC

Jazz Pharmaceuticals PLC shares are lower today, despite earlier gains. Mixed economic signals contribute to cautious sentiment ahead of the non-farm payrolls report.

5 авг. 2026 г., 19:36 UTC

News

Shares of Jazz Pharmaceuticals PLC are lower today, despite earlier gains. The company raised its full-year revenue guidance, driven by strong performance from Xywav.

4 авг. 2026 г., 20:04 UTC

Social Media
News

Jazz Pharmaceuticals PLC shares rise as analysts upgrade price targets, following strong Q2 results that beat revenue estimates and boosted 2026 sales guidance.

3 авг. 2026 г., 23:02 UTC

News

Jazz Pharmaceuticals reported Q2 revenues of $1.208 billion, exceeding expectations. Shares advanced in after-market trading following the raised full-year guidance.

31 июл. 2026 г., 23:21 UTC

Jazz Pharmaceuticals PLC shares are lower in after-market trading, pulled back from earlier session highs amid broader market declines, particularly in major tech stocks.

30 июл. 2026 г., 19:59 UTC

Jazz Pharmaceuticals shares are higher, reflecting broader market recovery amid significant gains in the technology sector. The stock is near the upper end of its one-month range.

29 июл. 2026 г., 18:26 UTC

Jazz Pharmaceuticals PLC is trading higher during Wednesday's session, with fluctuations within a routine range and positioned above its 20-day moving average.

28 июл. 2026 г., 23:46 UTC

Jazz Pharmaceuticals PLC shares are higher in after-market trading, recovering from an early low and remaining above the 20-day moving average.

27 июл. 2026 г., 19:37 UTC

Social Media

Jazz Pharmaceuticals PLC is trading higher, recently reaching a new 52-week high amid increased investor interest and significant average volume exceeding $50 million.

24 июл. 2026 г., 20:07 UTC

Jazz Pharmaceuticals PLC shares are lower today amid broader market dynamics influenced by recent oil price volatility, despite remaining above its 20-day moving average.

21 июл. 2026 г., 19:02 UTC

Jazz Pharmaceuticals PLC is trading higher today, despite no specific news. Positive sentiment in the semiconductor sector may be contributing to overall investor optimism.

20 июл. 2026 г., 23:36 UTC

News

Jazz Pharmaceuticals PLC will report second-quarter results on August 3, contributing to positive investor sentiment as shares trade higher after market hours.

Сравнение c конкурентами

Изменение цены

Jazz Pharmaceuticals PLC Прогноз

Целевая цена

By TipRanks

16.83% рост

Прогноз на 12 месяцев

Средняя 286.19 USD  16.83%

Максимум 315 USD

Минимум 229 USD

Основано на мнении 17 аналитиков Wall Street, спрогнозировавших целевые цены для Jazz Pharmaceuticals PLC на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

17 ratings

16

Покупка

1

Удержание

0

Продажа

Настроения

By Acuity

287 / 340Рейтинг в Здравоохранение

Новостные настроения

Свидетельства нисходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

help-icon Live chat